European Urology

Viewing slides 1-6 of 7

• S0302-2838(12)00632-X.title drag remove slide sort drag into slide Title A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
  
  Joshua J. Meeks, Joaquim Bellmunt, Bernard H. Bochner, Noel W. Clarke, Siamak Daneshmand, Matthew D. ... A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder ... Zoom
• S0302-2838(12)00632-X.introduction drag remove slide sort drag into slide Introduction • With radical cystectomy (RC) alone, the 5-yr survival rate for urothelial carcinoma of the bladder (UCB) can be up to 80% for organ-confined lymph node-negative disease.
  
  • It ... • With radical cystectomy (RC) alone, the 5-yr survival rate for urothelial carcinoma of the ... Zoom
• 22410 drag remove slide sort drag into slide Proposed strategy to incorporate perioperative systemic therapy for ... Zoom read this article »
• 22412 drag remove slide sort drag into slide Proposed strategy to incorporate perioperative systemic therapy for ... Zoom read this article »
• S0302-2838(12)00632-X.materials_and_methods drag remove slide sort drag into slide Materials and methods • Medline databases were searched for original articles published before April 1, 2012, with the search terms bladder cancer, urothelial cancer, radical cystectomy, neoadjuvant chemotherapy, and ... • Medline databases were searched for original articles published before April 1, 2012, with ... Zoom
• S0302-2838(12)00632-X.results drag remove slide sort drag into slide Results • Cisplatin-based neoadjuvant combination chemotherapy is an established standard, improving overall survival in MIBC.
  
  • Pathologic complete response appears to be an intermediate ... • Cisplatin-based neoadjuvant combination chemotherapy is an established standard, improving ... Zoom

Viewing slides 1-6 of 7